Opinion in France

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
Expert View
Expert View

'Le Cost Killer' goes easy on Renault

Renault chief executive Carlos Goshn, famed for his turnaround of Nissan, has announced an ambitious four-year plan to improve the French group's faltering performance. The plan, which features a move into new segments and a large-scale product offensive, is unlikely to cut as deep as his Nissan revamp, but as Datamonitor analyst Richard Carteau explains, Renault still has room to maneuver...

Published By Datamonitor
14 Feb 2006
CommentWire
CommentWire

3G mobile: the French ease terms

Published By Datamonitor
01 Jun 2001
CommentWire
CommentWire

A difficult year, but the future is still bright for EDF

French energy giant EDF has revealed a bigger than expected 40% drop in annual profits, prompting a fall in the company's share price. However, despite the disappointing annual results, EDF's outlook is strong. Indeed, potential plans to sell some French assets in order to boost liquidity would not only ease the company's debt pile but would also appease the European Commission.

Published By Datamonitor
16 Feb 2009
Expert View
Expert View

AAN 2012: Novartis presents new data in an attempt to boost confidence in long-term use of Gilenya

In keeping with American Academy of Neurology meetings of recent years, multiple sclerosis once again dominated proceedings at AAN 2012. Novartis used the platform to present new data from the extension FREEDOMS II trial to support the long-term use of Gilenya, and provided Phase II results for siponimod in relapse remitting multiple sclerosis.

Published By Datamonitor
03 May 2012
Expert View
Expert View

AAN 2012: research shows value of early disease identification, but caution in treatment is advised

At AAN 2012, Merck Serono presented data from a long-term study showing that early Rebif treatment significantly reduced the clinical progression of multiple sclerosis. However, early intervention should be used cautiously to avoid unnecessary treatment.

Published By Datamonitor
03 May 2012
CommentWire
CommentWire

ABB/Schneider: different strokes for different folks

Published By Datamonitor
15 Jan 2001
CommentWire
CommentWire

Abbott: AIDS group lawsuit attracts negative publicity

Abbott Laboratories has sued a French AIDS activist group, Act Up Paris, for launching a cyber attack against its website. This comes as a surprise to the industry which, after years of negative publicity generated by AIDS activists, is investing a great deal of effort in working with patient advocacy groups.

Published By Datamonitor
20 Jun 2007
CommentWire
CommentWire

ABN Amro / BNP Paribas: private progression

BNP Paribas [BNP.PA] is to enter the Dutch private banking market with the purchase of Nachenius, Tjeenk & Co from ABN Amro [AAB.AS]. The deal reflects both banks' continuing plans to create a pan European private banking network. If the same pro-active approach can be extended to developing their recently acquired businesses then both groups look very well-placed for the future growth.

Published By Datamonitor
21 Apr 2005
CommentWire
CommentWire

ABN Amro/PPR: moving into French retail banking

Published By Datamonitor
30 Jan 2001
CommentWire
CommentWire

Aftermarket: many garages unaware of changing regulations

A large proportion of garages and tire dealers in the major European markets are not aware of legislative changes due later this year. However, Germans are particularly well informed and optimistic, believing that their businesses will grow as the number of franchised dealers falls.<BR />

Published By Datamonitor
28 Mar 2003

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.